The penny stock of Galena Biopharma Inc (Nasdaq: GALE) is having another positve trading session after Wall Street analysts at Cantor Fitzgerald set a “buy” rating and a $4.00 price target on the stock yesterday. GALE shares are currently up 2.96% at $1.39 on volume of 1,458,273. ...
Monday’s penny stock alert, Advaxis Inc. (OTC: ADXS) traded as high as 0.106, 8.16% from Friday’s close, on volume of roughly 2.47 million shares. More importantly is that ADXS was given an “outperform” rating by Zacks Small-Cap Research citing that the stock of the biotech company was “undervalued.” Highlights include that Zacks has given a price target of $0.20 per ...
The British version of Bank of America Corp. (NYSE: BAC) received its second upgrade for the month of May on the penny stock by the firm that fed the London Whale. Lloyds TSB Group plc (NYSE: LYG)(LSE: LLOY.L) shares were upgraded by Wall Street analysts at JPMorgan Chase from an “underweight” rating to a “neutral” rating ...
We Know Penny Stocks which is why our penny stock picks and penny stock alerts are better than anyone who isn’t pumping and dumping. On March 2nd we listed Uroplasty Inc. (Nasdaq: UPI) stock as one that could double and needed to be added to the list of penny stocks to watch. Friday, UPI Stock reached as high ...
Shares in MELA Sciences Inc (Nasdaq: MELA), the medical device company that developed MelaFind, gained 17.2% on volume of 1.67 million in the last trading session before closing at $2.93 after analysts at Cowen initiated coverage on the penny stock. Cowen set an “outperform” rating on MELA stock which is currently trading at -26.83% below and -31.70% below ...
Again we come back to one of our best penny stock picks from 2010 OceanFreight Inc. (Nasdaq: OCNF), a dry bulk shipping company whose shares were just $0.48 in May, 2010. OCNF was acquired by DryShips Inc. (Nasdaq: DRYS) in July of 2011 for $19.85 per share. Why is that pertinent? Because on Tuesday, almost every small cap shipping company had coverage initiated by ...
Shares in the penny stock of CytRx Corp. (Nasdaq: CYTR) may be on a turn around after closing at $0.323 in the last trading session. In the screen of upgrades and downgrades stocks, CYTR is now covered by Wall Street analysts Roth Capital who set a “buy” rating on the penny stock. CytRx, a biopharmaceutical research and development company specializing in oncology, has gained 15.36% ...
Shares in the penny stock of Palatin Technologies Inc. (NYSE Amex: PTN) is now covered by analysts at Roth Capital with a “buy” rating. Palatin, a biopharmaceutical company dedicated to developing targeted, receptor-specific peptide therapeutics, has seen a significant drop in revenues compared to 2010 but could be looking at a rebound in the short-term.
Six weeks ago, Palatin announced that over 400 premenopausal women, diagnosed with female ...
Continue Reading →
Shares in the penny stock of Uranium Resources (Nasdaq: URRE) can not seem to stop the slide they are on even though analysts think URRE could more than double. Although volume was nearly 625 thousand in the last trading session, volume has been declining since the start of the year which could signify why the stock price of URRE ...
Syntroleum Corp. (Nasdaq: SYNM) saw the price of its penny stock rise 9 cents for a 10.84% gain in the last trading session on volume of 510,795 shares. Coverage was initiated by analysts at JMP Securities on Friday providing the first positive momentum in SYNM stock in almost two months. JMP Securities set an “outperform” rating on the penny ...
